Introduction
Conflicts of interest (COI) in medicine are commonly thought to occur when 'circumstances (arise) that create a risk that professional judgements or actions regarding a primary interest will be unduly influenced by a secondary interest', 1 although this definition is one of several. Over the past two decades, an extensive body of research has explored the sources and consequences of COI in medicine. In broad terms, this literature has two characteristics. First, it is principally concerned with financial (or 'pecuniary') COI. 1, 2 This emphasis is most likely because of the fact that financial COI are comparatively easy to report and measure. A focus on financial COI is especially evident in empirical work that assesses potential harms of COI. 3, 4 Second, the conflicts described are primarily those created by interactions involving physicians, researchers and the pharmaceutical industry. 1, 5 While the Institutes of Medicine definition cited above has provided some consistency in discussions about COI, there remains ongoing disagreement over causes and structures of such conflicts, how they arise, what their moral status is and what relationship they have to harm. 6 There are, for example, different views about how to define COI 7 and how seriously to take non-financial interests. 8, 9 Similarly, disagreement exists about whether to consider those with COI to be ethically culpable, ignorant or simply functioning within a system that has been corrupted by illegitimate, inappropriate or undue influences. 10 There are also debates about what constitutes a 'harm' arising from COI, whether the existence of a harm is necessary for COI to matter and whether or not the harms associated with particular behaviours, such as those involving industry, outweigh the benefits of these behaviours. [11] [12] [13] [14] [15] Given these continuing debates about COI, it appears likely that inconsistencies and confusions may influence COI policies and practices and attitudes of physicians and researchers. While there is a significant body of knowledge about how medical professionals think about and manage their interactions with industry, [16] [17] [18] [19] less is known about how medical professionals define and understand COI more generally. In order to gain a better understanding of the way that COI are understood in practice, we undertook a detailed study of the attitudes and behaviours of medical professionals and medical students. In this paper, we outline an empirically derived taxonomy of the understanding of, and attitudes towards, COI that has emerged.
Methods
The study followed a qualitative design in which data were collected from in-depth interviews and focus group discussions. Semistructured interviews were conducted with 25 medical professionals from a range of clinical specialties, including oncology, rheumatology, obstetrics and gynaecology, paediatrics, clinical pharmacology, general surgery and general practice. Many of the participants were also medical researchers or medical educators. They had all been in practice for at least 10 years and were based in metropolitan areas across Australia. Many had previously worked in hospitals overseas. Initial recruitment was performed through a convenience sample of clinical practitioners in public and private practice identified by study investigators, with potential participants recruited directly using publicly available contact details. A subsequent wave of recruitment aimed to maximise variability in terms of medical specialty, level of seniority and gender. Recruitment was not based on participants' known views about COI -that is, we did not deliberately seek out people who were likely to have extreme (e.g. libertarian or restrictive) views. Interviews took place in person, by telephone or Skype.
In addition to interviews, six focus group discussions were conducted involving medical students from six medical schools in New South Wales, Australia (n = 49). Each group comprised students from different universities and at different stages of their education, from the first to sixth year of study. Students were recruited through advertisements on student-run medical societies and faculty mailing lists. Would-be participants contacted the research team by email and chose a group to attend from several times and locations, making allocation largely the result of availability. Participants were given a $50 gift card. Interviews and focus groups followed similar question routes, focusing on participants' understanding of the meaning of 'conflict of interest', views about what makes COI more or less serious or blameworthy and how they should be managed. They were also asked about their own experiences of COI and how these had been managed.
Transcripts were analysed by two of the authors (JW and CM) using framework analysis. Framework analysis involves systematically looking for similarities and differences in data around (in this case) predetermined themes. 20, 21 A coding matrix was developed using Microsoft Excel based on the interview design and analysis of pilot interviews. Transcripts were coded and compared as they were received, enabling the ongoing refinement both of the coding matrix and question routes. In the tables accompanying this manuscript, we include representative quotes for their illustrative value. In some cases, details in quotes that do not affect meaning have been slightly altered to ensure speakers cannot be identified. Ethics approval was granted by the University of Sydney.
Results
Two broad attitudes towards COI were evident from the interviews and focus group discussions. The majority of participants adopted a critical perspective: that COI are potentially harmful and need to be avoided or managed. A minority were more defensive, either denying that COI exist at all or admitting that they exist but considering them unproblematic. Within each approach, there was considerable variation in how participants defined COI, what they saw as the causes of and sustaining conditions for COI, how (if at all) they linked COI to moral wrongdoing and harm and how (if at all) they should be managed.
The critical discourse

Varied definitions of COI
Participants commonly offered 'common sense' definitions of COI as conflicts of responsibilities, ideals, goals or interests. Conflicts were generally seen to present issues for individuals, although it was noted occasionally that they could also affect organisations. Many of the definitions offered also reflected an idea of a hierarchy of interests. Participants often referred to COI in terms of 'primary' (more morally legitimate) and 'secondary' (less morally legitimate or morally compromising) interests, although often without explicitly using these terms (Table 1) . Such primary interests were, however, generally not well defined but rather assumed or implied. Furthermore, where they were referred to directly, this was usually in vague terms, such as in relation to 'interests of the patient'. Secondary interests were usually framed as self-interest or benefits to an institution rather than to a patient, research participant or student. Self-interest could, in turn, be financial, interpersonal or statusrelated.
While in most cases, it was assumed that the kinds of interests regarded as secondary -in the terms defined above -conveyed less moral force than primary interests, there were situations where the moral distinction between the two categories was unclear. In these cases, both were regarded as legitimate, albeit arising from different responsibilities or loyalties. Examples of these kinds of conflicts included situations where doctors were responsible both for the care of patients and for ensuring the financial viability of their units, or for conducting research and recruiting patients to trials or for considering the sustainability of health systems and promoting industry innovation and investment.
'Causes' and sustaining conditions of COI Participants' views about the 'causes' of COI could be broadly categorised as systemic, individual and relational. Systemic -or structural -causes encompassed the mechanisms by which research, political and health system arrangements appeared to drive the generation of COI. Some of these were explained by participants in conceptual terms, such as a shift in the orientation of medicine towards business, or more concretely, as a result of demands to cut cost, set targets and conform to funding models. Individual causes of COI referred to the desire for personal gain. In some cases, this desire was recognised as legitimate -for example, compensation for years of study or for large student loans -while in others -such as a quest for material wealth -it was seen as a serious moral failing. Relational causes of COI were linked to relationships, such as those involving friends, family and pharmaceutical company representatives.
As well as identifying causal factors underlying the formation of COI, participants identified conditions that supported their development or sustained behaviours that compromised judgement and decision making once they had emerged (Table S1 , Supporting information). These included: power imbalances, exacerbated by dependence, desperation and asymmetry of information; the persistence of potentially conflicting roles and associated normalisation of structures and practices that create or maintain COI and moral failings on the part of those who have COI or put others in the position of having COI (e.g. pharmaceutical companies)
COI and moral wrongdoing
In addition to the variations in how the concept of COI was understood, there were differences of opinion about the degree to which COI represented moral failings. For some, allowing oneself to have a COI constituted, or bordered on, outright corruption. Doctors who resisted having or gaining from COI were, in contrast, described as having integrity and as being reflective, honest and of good character. For others, the claims about moral failure needed to be qualified by recognition that people could have COI, and even be compromised by them, in the absence of malicious or even deliberate intent. Such qualifications were sometimes buttressed with statements about the ubiquity of COI and reminders that systems are in place that force people to behave in particular ways.
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Many participants recounted situations in which they had experienced outrage at having been accused of having COI or described difficulties associated with raising the question of COI with colleagues and peers. A related theme running through many interviews was a sense of unfairness about the different moral standards that were often applied in discussions about COI. A widely held perception, for example, was that people working in industries other than medicine also have COI but escape the scrutiny to which medical professionals are unfairly subjected.
Harms caused by COI
Participants identified a wide variety of harms that could result from COI (Table 2 ). These included harms to patients, which could be physical, financial, emotional or existential (e.g. loss of agency or autonomy If the partner has a good sperm count and they've got normal tubes, then all you need to do is to get them to ovulate. But it takes a little bit of skill and time, and it's not terribly high remuneration for the doctor. But if you put them on an IVF programme, because they don't need IVF, they are going to be the top performers in terms of getting pregnant. Now so what this clinic did was that instead of charging $300 or $400 for the ovulation induction, they charged $2,000 which was more than the co-payment for IVF at that time. So that all of the patients looked at it and said well I only need ovulation induction but IVF is actually cheaper, I'll do IVF. And so they all proceeded through IVF, which they didn't really need, and of course that's a great way of improving your pregnancy rate.
Patient well-being (physical and/or financial)
• Referring or sending pathology specimens to a company in which a practitioner has a financial stake [IVF Clinician] it really starts to become a little bit naughty I think, when the doctors actually own the imaging and the pathology firms as well, and they send the pathology, like I was talking to you about the genetics, like I think that's really unethical. Those patients just go and have their genetics analysis done, and the doctor's almost certainly making a profit ultimately as a shareholder from that.
Interpersonal
• Using influence in a competitive selection process such that a family member gets a job or gets into a competitive degree course [Medical educator] The other issue is about members of faculty's families being students within the programme. The Dean's son has been a student of this faculty; the child of Prof D. has been a student of this faculty; the child of Prof M. has been a student of this faculty.
Others competing for resources
• Referring patients to a friend or family member [Medical student] The dad is the doctor and the daughter is the physio and they both work within the same practice. So usually -so what happened was, I witnessed a patient who went in and had lower back pain and he was like, well can't really do much in terms of treatment, I can give you pain relief, but what would help is if you go and see a physio and referred to the daughter who was next door, being like oh you can go and see her, she's free in half-an-hour and just sort of slid him into that pathway when there were other options, such as going to see a community health centre or something like that.
Patient well-being (physical and/or financial), other competing for resources
Status building or maintaining
• Working with industry to cement a reputation as a leading expert [Oncologist] You know it's not monetary, but effectively if you do a lot of research that's industry sponsored, then you have a lot of opportunities to present your research and be visible in the oncology circles, where you will become an expert. And it's the status of being an expert and the respect of your peers and the recognition as an authority in a particular discipline, is actually non-financial but a very important kind of interest, which is not trivial, and it's very hard to tease out the element that is legitimate, meaning if you are an expert in something, eventually you're an expert in it, irrespective of who pays for the work that you do.
Objectivity in research and as a clinical leader
where doctors' COI restrict the information or options that are presented to patients). Participants also identified harms that may impact not merely individual patients but also the health and social systems more broadly; these harms were of an economic, epistemic (knowledge-related) and professional nature. Economic harms could result from when COI led to practices that are more costly than necessary; epistemic harms could result from biased education, research or publication, and COI-related scandals could both threaten trust in the institutions of medicine and cause their (further) moral degradation. While most participants were easily able to identify harms they felt may result from COI, they varied considerably in their views as to how COI are related to harm and whether COI need to cause harm in order to matter. For some participants, an actual harm had to have occurred in order for a COI to be considered significant. Others took this further, arguing that a COI could not even be said to exist if it did not cause harm. In contrast, other participants argued that a COI can exist (and matter) irrespective of whether or not it generates any harm. For these people, it was the risk or potential for harm and the incentive to act in a harmful manner that mattered as much as any actual harm.
Approaches to managing COI
Finally, there was a broad variety of views about how COI can and should be managed. Some participants expressed confidence that COI could be effectively managed and even eradicated. Others were more sceptical, citing the allegedly widespread prevalence of COI, the degree to which healthcare and health professions were seen to be embedded in unchangeable social structures [Oncologist] you hear about people saying we can use the fancy robots to do your operation next week if you pay us an extra $12,000, but if you want to have the conventional waiting list then it will be another month before your operation. That sort of…that's a clearly a very personal financial conflict. And they're very common in medicine at the moment. And often potentially you know, leading to social harms for patients, not necessarily medical harms.
[IVF Clinician] Well I think it's about erosion of choice for patients … So I worry about the choice, that there might be more influence brought to bear in the decision making process, or that the patient might be more vulnerable to persuasion, versus a free choice. So yeah I think it's about how the information might be packaged for the patient, I think the power relationship doctor and patient is…we all are aware of it and working with it, and I think maybe that shifts a little if it was in that particular circumstance. Yeah my main worry about harm is that people might end up by choosing, or not choosing to have something, being persuaded to have something that they may not have chosen had they been given a bit more time. Economic harms -to health systems -to individuals [IVF Clinician] Well it can matter financially both to the state, because the taxpayer is paying more than they need to, and to the patient who may be paying a bigger out of pocket fee than they need to.
Epistemic -to knowledge generation -to policymaking -to clinical decision making [Medical student] So they came in and did a little teaching session with the nurse who was the CNC for that type of dressing, but the vacuum dressing manufacturer was there. They're like, well when you become doctors, think about all the benefits of using this vacuum dressing machine.
[Medical student] like it's a fine line when you need a good reference from someone to get on a training programme, but they're also treating you in an inappropriate manner. So you've got the conflict of your own personal ethics and what you consider to be appropriate and then you've got the conflict of medicine being such a competitive industry that you need that reference if that's your only surgery rotation, for example and you want to be a surgeon and every reference counts.
[Medical student] I went to a Women in Medicine evening and they were talking about bullying and harassment of women in medicine, similar thing, you'd have your agents of change, but the youngest woman on the panel, who is an amazing cardiothoracic surgeon, was saying that she had been bullied and harassed and didn't report it. So it was kind of a confusing message [laughs] but I think kind of illustrated the point that it's one thing to picture all this stuff, but when you see people, you're kind of expecting that organisational culture. Social -loss of trust in science -loss of trust in the medical profession
[Medical educator] it's really important that medicine and medical educators, and health carers and healthcare professionals in general, are trustworthy. Anything that have the ability to undermine their trustworthiness or the perception of the public of their trustworthiness, I think needs to be managed very carefully.
[Medical student] I think patients would perceive that differently if you were getting paid to prescribe a drug compared to if you were going to conferences to improve your skills and your knowledge, patients would appreciate that a lot more and that would be better for the patient-doctor trust relationship I think … I think if you're being paid money to go to Coolum or Surfers Paradise or something, as opposed to Canberra, that matters.
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The defensive counter discourse
While the majority of participants were convinced of the existence and seriousness of COI, others strongly contested the view that they were prevalent in medicine or had a significant impact. The latter drew attention to the existence of a variety of counter-forces they believed acted to minimise the likelihood or impact of conflicts. These protective forces could be classified as moral, cognitive and structural. Moral protection was seen to derive from the commitment of medical professionals to their patients, research participants, students and the public (i.e. to their 'primary' interests), the strength of this commitment being sufficient to overcome challenges presented by lessvalid interests. Some also emphasised that, as with doctors, medical industries also had interests that included benefits to patients and the society as a whole. Cognitive protection arose from the capacity for medical professionals to gather and interpret information from a wide range of sources and from their ability to reflect on their own motivations and decision-making processes. Structural protections against the adverse effects of COI included the formal obligations imposed on physicians and other stakeholders (e.g. the pharmaceutical industry) to comply with laws and regulations. They were also postulated to arise from the likelihood that harming patients, whether as a consequence of medical or commercial self-interest, would not be tolerated by the market.
Not surprisingly, those who espoused a more defensive position tended to deny that COI were invariably harmful. These participants framed primary and secondary interests or roles as being, on occasions, compatible or even mutually reinforcing (i.e. as 'dualities' or 'multiplicities' of interests). With respect to management, there was a tendency in this group to claim that COI were simply 'part of life' and should be treated in a systematic, non-punitive manner. There was strong resistance among this group to the idea of an inflexible system of regulatory oversight, particularly if it eroded the capacity to respond to COI within the medical community itself.
Discussion
Our results demonstrate considerable heterogeneity in the ways in which practising doctors, researchers and medical students understand COI, their causes and what perpetuates them, their moral status, their relationships to harm and how they should be managed. In the 'real worlds' of medical research, practice and education, views about COI are highly varied. The variation likely relates to personal experience, professional role and ethical and cultural background.
The systematic classification of the range of approaches to COI in our study is subject to the nature and composition of our study population. Although we sought to recruit participants from a wide range of ages and professional groups, it is possible that those who agreed to take part may have constituted a sample with particular interests in or positions on COI (selection bias). Against this is the wide variation in responses we obtained, which suggest the absence of a particular bias. It is also possible that, given the stigma commonly associated with COI, some participants may have exaggerated their condemnation of practices in order to present themselves in a positive light (so-called 'social desirability bias'). However, this too is unlikely to have created a false impression of variability. Finally, while interviews were conducted with clinical experts and medical educators living in metropolitan areas throughout Australia, the focus group discussions took place only in the state of New South Wales, suggesting the possibility of a geographical bias. This is, however, unlikely to have affected generalisability as medical curricula are determined nationally and by individual universities.
The wide variation in participants' views raises questions about current and proposed strategies for managing COI in health and biomedicine. Broadly speaking, three approaches are currently employed: (i) education of doctors, researchers and students; (ii) requirements for disclosure of interests in relevant contexts and (iii) proscription of particular activities and relationships and the creation of 'firewalls' to prevent COI from arising or causing harm.
The problem with relying on education to address COI is that, as our results confirm, there is little consensus about the prevalence, causes, moral status and harmfulness of COI that could provide a basis for a uniform or consistent programme for aligning people's views. Furthermore, debates about COI are underpinned by distinctly different ideologies and attitudes regarding the role of commerce and the market in medicine and the corresponding roles of doctors (or providers of services) and patients (or consumers). Such contested ideologies are unlikely ever to be brought into alignment under a single set of educational principles. Given this, it appears naïve to assume that the aim of correcting a simple knowledge deficit through education could overcome disagreement about COI and about appropriate standards of behaviour.
Reliance on disclosure as a means for avoiding the harms associated with COI is also problematic, as has been widely noted. This is partly because disclosure places the onus on the recipients of information to interpret what is to be disclosed. This might be difficult because it is unclear what recipients should make of the disclosure in relation to the veracity and integrity of the clinical recommendations, teaching or research findings that follow the disclosure: should they, for example, disregard subsequent information entirely, trust it more because COI have been disclosed or 'take the COI into account' when evaluating the data? Patients or research participants might also feel pressured to comply with whatever advice or requests might follow the declaration of a conflict. 22 In addition, disclosure of COI does not necessarily lead to changes in attitudes or behaviours. Rather, individuals may become even less cautious once potential conflicts have been declared (a phenomenon referred to as 'moral licensing'). 22 Finally, mandatory disclosures of all possible COI, however defined, may create 'noise' that obscures genuine and serious COI. 23 Our results provide a powerful additional reason for scepticism about disclosure as the principal means for managing COI: that those disclosing a 'COI' are likely to have idiosyncratic understandings of what it is they are disclosing, and why they are doing so, and those who are expected to interpret the disclosure are likely to interpret and respond to them in equally idiosyncratic and unpredictable ways.
The limitations of education and disclosure as means for limiting and managing COI suggest that more active management strategies are needed. These may comprise stricter rules, including, where necessary, enforceable regulations about the kinds of relationships and interactions that are permitted in different settings at different times and what kinds of firewalls need to be put in place for avoiding COI and preventing harm. For example, rigorous limits could be placed on pharmaceutical industry support for medical education, and processes could be established to separate the various influences on research, including interpretation and presentation of data. Given the wide variation in how COI are conceptualised, the rationale for both internal and external regulation would need to be clearly articulated so that those affected are aware of how the regulatory strategies engage with the different concepts of interest.
A more sophisticated and complex regulatory approach, as is being proposed here, would not seek to apply rules in a rigid and inflexible manner -in part because identification and management of COI is fundamentally contextual and requires dialogue and deliberation and in part because medical professionals may be resistant to a routine, dispassionate approach to the management of COI. Any new policies would therefore need to be based on open, inclusive and democratic deliberation involving all stakeholders and cover both practical issues and the fundamental philosophical questions underlying disagreement about COI.
